Live Quote · NASDAQVRDNHealthcare· Biotechnology

Viridian Therapeutics, Inc.

$29.96▼ 4.71%($-1.48)
MKT CAP $3.40BNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
74/100
▌ Solid
50
Valuation
40
Profitability
95
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VRDN research report →

Analyst Price Target
$40.00+33.5% vs. today

Range $31 – $47

Analyst RatingBuy
15 Buy2 Hold0 Sell

Price Chart

+9.62% · this period
$33.78$23.54$13.30Nov 19May 22Nov 19
52-Week Range79% of range
Low
$13.18
Current
$29.96
High
$34.29